American International Group’s Marker Therapeutics MRKR Stock Holding History

American International Group’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,775	Closed	-$40	–	3217
2021 Q1	$40	Buy	1,775 +4	+0.2%	+$92	﹤0.01%	3032
2020 Q4	$26	Buy	1,771 +6	+0.3%	+$93	﹤0.01%	3058
2020 Q3	$27K	Sell	1,765 -40	-2%	-$730	﹤0.01%	3015
2020 Q2	$37K	Buy	1,805 +201	+13%	+$4.4K	﹤0.01%	2968
2020 Q1	$30K	Sell	1,604 -93	-5%	-$2.37K	﹤0.01%	2848
2019 Q4	$49K	Sell	1,697 -14	-0.8%	-$509	﹤0.01%	2882
2019 Q3	$87K	Sell	1,711 -12	-0.7%	-$709	﹤0.01%	2689
2019 Q2	$137K	Buy	+1,723	New	+$102K	﹤0.01%	2473

Other funds holding MRKR

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American International Group's MRKR Position: Q2 2021 in Review

American International Group sold out of Marker Therapeutics (MRKR) in Q2 2021, closing a stake of 1,775 shares — an estimated $40 sold.

American International Group first reported a position in MRKR in Q2 2019 and held it in 8 quarters. The position peaked at $137K in Q2 2019. 74 funds tracked by Wall St. Rank hold MRKR as of Q2 2021.

American International Group reported no remaining Marker Therapeutics position as of Q2 2021 after selling out during the quarter.
American International Group sold 1,775 Marker Therapeutics shares in Q2 2021, an estimated $40.
American International Group first reported a position in Marker Therapeutics in Q2 2019 and held it in 8 quarters.
American International Group's Marker Therapeutics position peaked at $137K in Q2 2019.
74 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.